Understanding the Development Challenges Associated with Emerging Non-Traditional Antibiotics
JW Marriott Washington DC 1331 Pennsylvania Avenue NW, Washington, DC, United StatesConvened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and supported by a cooperative agreement with FDA, this public event will focus on the range of non-traditional pharmaceutical approaches being developed to combat bacterial infections. Kevin Outterson and John Rex to present.
GARDP Live Discussion Webinar: PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?
WebinarIn this webinar, William Hope will talk about the role of pharmacokinetics and pharmacodynamics for antimicrobial drug development. He will discuss the EMA guideline on the use of PK/PD and basic studies to inform dose finding strategies. He will also advise on realistic benchmarking, endpoints, and interpretation of study results.
Payment Reform Pathways for Antimicrobial Drugs: Duke-Margolis Center for Health Policy Roundtable Meeting
Washington, DCFacilitating Payment Reform Pathways for Antimicrobial Drugs through FDA and CMS Collaboration As you know, the rise in antimicrobial resistant infections is a major public health threat. Few treatment options […]
FDA Development of Non-Traditional Therapies for Bacterial Infections Workshop
FDA White Oak Campus - Building 31 10903 New Hampshire Ave, Silver Spring, MD, United StatesThe Food and Drug Administration is holding a public workshop entitled “Development of Non-Traditional Therapies for Bacterial Infections." The purpose of the public workshop is to discuss the general development […]
Next Generation Dx Summit: Investment Plenary Panel – Changing Approaches to Sustainable Funding in Diagnostics
Grand Hyatt Washington 1000 H St NW, Washington, DC, United StatesToday, many innovators in the diagnostics industry struggle for funding, and yet news of large scale acquisitions or large (over $30M) funding rounds pops up regularly. How can innovators better […]
ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
Intercontinental Lisbon R. Castilho 149, Lisbon, PortugalKevin Outterson to present
Vaccines Against Clostridium difficile Infection (CDI): A Roadmap for the Future
NIAID Conference Center 5601 Fishers Lane, Rockville, MD, United StatesThere are 453K new C. difficile infections (CDI) every year and 83K recurrent infections, yet there are no licensed vaccines against this important nosocomial pathogen. The current pipeline of clinical-stage […]
Antibacterial drugs: Clinical development for non-developers Webinar
WebinarPart 2: Development of antibacterial drugs targeting specific pathogens The overall goal of this series of webinars is to provide, for the non-clinical developer, an understanding of the risks of development […]
FDA Commissioner Unveils Plan to Combat Antibiotic Resistance – Live Webcast
At least 2 million Americans a year contract an antibiotic-resistant infection, the Centers for Disease Control and Prevention reports. So, what can the U.S. do to safeguard public health amid […]
The AMR Challenge Launch Event
The Roosevelt Hotel 45 E 45th St, New York City, NY, United StatesThe AMR Challenge encourages global leaders to make formal commitments that further progress against antimicrobial resistance. Your efforts could contribute to solutions that protect humans, animals, and the environment from […]